Lanthanum carbonate Granule Formulation
SPD405-127
Phase 1 small_molecule completed
Quick answer
Lanthanum carbonate Granule Formulation for End Stage Renal Disease is a Phase 1 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- End Stage Renal Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed